Eli Lilly paused shipments of Mounjaro to the UK while preparing for a list price increase of up to 170% from September. Allocations were implemented for pharmacies and providers to manage supply and protect patient access, with legal protections against inappropriate stockpiling. Orders are expected to resume on 1 September. The price rise could lift a month's supply of the highest dose from £122 to £330. Wholesalers were told to stop taking orders after demand surged ahead of the increase, prompting reports of panic buying and warnings against black market purchases. Mounjaro (tirzepatide) competes with Ozempic and is available on the NHS.
The manufacturer of the weight loss drug Mounjaro has paused shipments to the UK ahead of a significant price rise for the treatment due to come into effect next month. The US pharmaceutical company Eli Lilly is due to increase the UK list price of the drug by up to 170% from September amid a White House push to get drugmakers to raise medicine prices in Europe to allow for price cuts in the US.
People using Mounjaro have been warned against switching to black market sellers or bulk buying. While many pay for Mounjaro in the UK, it became available on the NHS at the end of June, and Lilly says the higher price will not affect those who get it through the health service. The drug also known by its generic name tirzepatide has become a popular alternative to the most well-known weight loss drug, Ozempic.
Collection
[
|
...
]